Immatics (IMTX)

• Market cap: $1.18B
• 1 day: -5.87%
• 5 days: -5.77%
• 1 month: -14.51%
• 3 months: -21.2%
• 6 months: -13.31%
• Year to date: -17.13%
• 1 year: 34.26%
• 5 years: -27.41%
• 10 years: -9.79%
• Sector: Healthcare
• Industry: Biotechnology

About: Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Employees: 407